Trading Signals: ATHX Stock Price Prediction and Forecast (Tue. Jun. 12, 2007 - Fri. May. 13, 2022)(Athersys, Inc.)
| ATHX latest price $0.8954 (-3.74%) ($0.8947 - $0.8954) on Mon. Feb. 28, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.17% (three month average) | RSI | 43 | Latest Price | $0.8954(-3.74%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATHX advances 1.1% a day on average for past five trading days. | Weekly Trend | ATHX declines -2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATHX advance at 0% a week (0% probability) TBT(15%) VXX(11%) XHB(10%) ARKK(8%) XRT(8%) | Factors Impacting ATHX price | ATHX will decline at least -2.585% in a week (0% probabilities). BWX(-26%) BNDX(-24%) TLT(-19%) XLE(-15%) XLU(-14%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.585% (StdDev 5.17%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $0.93 | 5 Day Moving Average | $0.91(-1.6%) | 10 Day Moving Average | $0.89(0.61%) | 20 Day Moving Average | $0.93(-3.72%) | To recent high | -19.3% | To recent low | 12.7% | Market Cap | $176m | | | | Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH. |